Location History:
- Cary, NC (US) (2001)
- Research Triangle Park, NC (US) (2002)
- Durham, NC (US) (2006 - 2012)
Company Filing History:
6 out of 2,198 
3 out of 356 
2 out of 281 
Years Active: 2001-2012
Title: David Norman Deaton: Innovator in Pharmaceutical Chemistry
Introduction
David Norman Deaton is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on farnesoid X receptor agonists. With a total of 11 patents to his name, Deaton has established himself as a key figure in the development of novel therapeutic compounds.
Latest Patents
Among his latest patents, Deaton has focused on the development of novel substituted isoxazole compounds. These compounds are part of pharmaceutical compositions that have therapeutic uses and processes for their preparation. His work on farnesoid X receptor agonists highlights the potential for these compounds in treating various medical conditions.
Career Highlights
Throughout his career, David Norman Deaton has worked with notable companies in the pharmaceutical industry. He has been associated with SmithKline Beecham Corporation and GlaxoSmithKline LLC, where he contributed to various research and development projects. His expertise in pharmaceutical chemistry has been instrumental in advancing the field.
Collaborations
Deaton has collaborated with several professionals in his field, including Frank Navas, III and Paul Kenneth Spearing. These collaborations have further enriched his research and have led to the successful development of innovative pharmaceutical solutions.
Conclusion
David Norman Deaton's contributions to pharmaceutical chemistry and his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the industry positively, paving the way for future developments in therapeutic compounds.